Old National Bancorp Axsome Therapeutics, Inc. Transaction History

Old National Bancorp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 17, 2023	SELL	$69.25 - $82.21 $256,917 - $304,999	-3,710 Reduced 44.92%	4,550 $317,000
Q1 2023 Apr 19, 2023	SELL	$58.39 - $75.0 $536,312 - $688,875	-9,185 Reduced 52.65%	8,260 $509,000
Q4 2022 Feb 03, 2023	SELL	$39.94 - $79.72 $366,369 - $731,271	-9,173 Reduced 34.46%	17,445 $1.35 Million
Q3 2022 Feb 17, 2023	BUY	$36.06 - $69.85 $330,778 - $640,734	9,173 Added 52.58%	26,618 $1.19 Million
Q3 2022 Nov 08, 2022	BUY	$36.06 - $69.85 $32,454 - $62,864	900 Added 3.5%	26,618 $1.19 Million

Q2 2022 Jul 25, 2022	BUY	$21.74 - $46.75 $559,109 - $1.2 Million	25,718 New	25,718 $985,000

290

37.1M

401K

464K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.44B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

Stay updated on Old National Bancorp with notifications on news.